Verona Pharma American Depositary Share total non-operating income/expense for the twelve months ending September 30, 2024 was $0.004B, a 72.94% decline year-over-year.
Verona Pharma American Depositary Share annual total non-operating income/expense for 2023 was $0.014B, a 87.26% increase from 2022.
Verona Pharma American Depositary Share annual total non-operating income/expense for 2022 was $0.007B, a 58.81% decline from 2021.
Verona Pharma American Depositary Share annual total non-operating income/expense for 2021 was $0.018B, a 91.07% increase from 2020.
Verona Pharma American Depositary Share Total Non-Operating Income/Expense 2017-2024 | VRNA